Who: Institute of Bioengineering and Nanotechnology (IBN), Singapore.
What: Researchers have developed a genetic test utilizing gold nanoprobes to determine the correct dosage of blood thinning drugs for the treatment of stroke, heart problems and deep vein thrombosis. See “Nanoprobe-based genetic testing”
Where: Faster and more cost-effective genetic tests.
When: IBN’s nanoprobe technology is currently on trial at Singapore’s KK Women’s and Children’s Hospital in relation to carbamazepine, a different drug that is used for epilepsy treatment.
